ClinicalTrials.Veeva

Menu

To Examine if the Mother's Glucose Levels and Glucose Levels in the Blood Can Predict Cord Hypoglycemia in Newborns at Risk.

T

Tel Aviv Sourasky Medical Center

Status and phase

Unknown
Phase 3

Conditions

Neonatal Hypoglycemia

Treatments

Procedure: Blood samples

Study type

Interventional

Funder types

Other

Identifiers

NCT02838875
0253-16-TLV

Details and patient eligibility

About

Background Neonatal hypoglycemia is one of the most common metabolic disorders in neonatology. Maintaining stable levels of glucose in the transition from fetal life to life after birth is very important. Yet, except for the recognizing of at-risk populations, there are not many individual measures which can help and predict which newborns (from at-risk populations) will develop hypoglycemia and which will not.

OBJECTIVE our objective is to try to characterize by the mother's glucose levels at birth and by umbilical cord glucose levels who would be at increased risk of hypoglycemia in the hours after birth in the population that is at increased risk of this complication in advance.

Full description

Background Neonatal hypoglycemia is one of the most common metabolic disorders in neonatology. Maintaining stable levels of glucose in the transition from fetal life to life after birth is very important. Yet, except for the recognizing of at-risk populations, there are not many individual measures which can help and predict which newborns (from at-risk populations) will develop hypoglycemia and which will not.

OBJECTIVE our objective is to try to characterize by the mother's glucose levels at birth and by umbilical cord glucose levels who would be at increased risk of hypoglycemia in the hours after birth in the population that is at increased risk of this complication in advance.

PATIENTS & METHODS All women who arrived to the delivery room at Lis hospital and which the newborn is about to undergo glucose levels follow-up after birth regardless the study, because his affiliation to the at-risk population including: delivery below 37th week, maternal diabetes during pregnancy and newborns in weight under percentile 10 or above percentile 90 by Dolberg graphs.

Enrollment

1,000 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Single pregnancy

  2. Vaginal or cesarean birth.

  3. Births where there is an indication of neonatal hypoglycemia follow-up - one or more of the following:

    • Delivery week below 37 full weeks.
    • Maternal diabetes during pregnancy (gestational diabetes or pre-gestational).
    • Newborn under percentile 10 by Dolberg graph.
    • Newborn above percentile 90 by Dolberg graph.

Exclusion criteria

  1. Multiple Pregnancy
  2. pregnancies in which there is no indication for routine monitoring of glucose levels after birth

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1,000 participants in 1 patient group

Pregnant women at risk population
Experimental group
Description:
women who arrived to the delivery room at Lis hospital and which the newborn is about to undergo glucose levels follow-up after birth regardless the study, because of their affiliation to the at-risk population.
Treatment:
Procedure: Blood samples

Trial contacts and locations

0

Loading...

Central trial contact

Yariv Yogev, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems